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Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) belongs to the
steroid/thyroid hormone receptor superfamily and may contribute to the pathogenesis of
obesity. It has not conclusively been established, however, whether its role is pro- or anti-
adipogenic.
Methods and Results
Gene silencing ofCoup-tfII in 3T3-F442A preadipocytes resulted in enhanced differentiation
into mature adipocytes. This was associated with upregulation of the Notch signaling target
geneHey1. A functional role of Hey1 was confirmed by gene silencing in 3T3-F442A preadi-
pocytes, resulting in impaired differentiation. In vivo, de novo fat pad formation in NUDEmice
was significantly stimulated following injection of preadipocytes withCoup-tfII gene silencing,
but impaired withHey1 gene silencing. Moreover, expression ofCoup-tfIIwas lower and that
ofHey1 higher in isolated adipocytes of obese as compared to lean adipose tissue.
Conclusions
These in vitro and in vivo data support an anti-adipogenic role of COUP-TFII via downregu-
lating the Notch signaling target gene Hey1.
Introduction
Over the last decades obesity and its consequences worldwide have become a major health
problem. Indeed, obesity is associated with an increased mortality from cardiovascular disease,
some forms of cancer, diabetes and kidney disease [1].
Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII, also known as
NR2F2, nuclear receptor subfamily 2 group F, member 2) is a nuclear orphan receptor that
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belongs to the steroid/thyroid hormone superfamily and may contribute to the pathogenesis of
obesity. COUP-TFII was reported to play an important role in adipogenesis and energy homeo-
stasis [2], and it has a documented role in tumor angiogenesis through the regulation of Ang1/
Tie2 signaling or VEGF/VEGF receptor 2 signaling [3]. Coup-tfII is expressed in adipocytes as
well as in the vascular compartment of mainly white adipose tissue, but recent reports on its role
in adipogenesis have been contradictory [2, 4, 5]. Coup-tfII expression decreases during differen-
tiation of preadipocytes and its overexpression impairs adipogenesis by repressing the expression
of pro-adipogenic factors in adipocytes [5]. In addition, reduction of Coup-tfIImRNA expression
allows fibroblasts to differentiate into fat cells, indicating that COUP-TFII acts downstream of
the hedgehog signaling and is required for the full anti-adipogenic effect of this pathway [5]. In
agreement, Okamura et al. reported that Wnt/beta-catenin signaling activates the expression of
Coup-tfII, which in turn represses PPARγ gene expression, resulting in inhibition of adipogenesis
[4]. In contrast, reduced adipose tissue mass and improved glucose homeostasis were shown in
heterozygous COUP-TFII mice as compared to wild-type (WT) mice [2]. It is thus not conclu-
sively established whether COUP-TFII has a pro- or anti-adipogenic potential.
COUP-TFII is considered to be a major regulator of Notch signaling pathways [6].
COUP-TFII homodimers inhibit arterial differentiation of venous endothelial cells through
direct binding to the promoter regions of the Notch target genes Hey1 and Hey2, causing tran-
scriptional repression [7]. Interestingly, it was shown that endothelial cells and adipocytes have
a common progenitor [8]. Conflicting data have been reported on the role of Notch signaling
in adipogenesis. Garces et al. first showed that Notch1 is required for adipogenesis [9], whereas
later it was argued that Notch is dispensable in adipocyte specification [10]. More recently it
was reported that inhibition of canonical Notch signaling inhibited adipogenesis [11], whereas
activation of this pathway stimulated adipogenesis [12]. In conflict with these data, it was
reported that inhibition of Notch signaling promotes differentiation of preadipocytes [13–15].
In addition, a dual role for the Notch target geneHes1 in adipocyte development was suggested
[15], whereas the role of Hey1 in adipogenesis was not further explored.
To clarify the functional role of COUP-TFII and Notch-Hey1 signaling in adipogenesis, we
used established mouse models of in vitro adipocyte differentiation and in vivo adipogenesis.
Materials and Methods
In vitro models
Gene silencing in 3T3-F442A preadipocytes. To obtain long term stable gene silencing of
Coup-tfII or Hey1 in 3T3-F442A preadipocytes [16], the ‘MISSION shRNA lentiviral transduc-
tion particles’ system (Sigma-Aldrich, St. Louis, MO) was used as described elsewhere [17].
For COUP-TFII (NM_009697), five different clones were tested (TRCN0000026167-026232-
054474-054475-312204), as well as for the Notch signaling target gene Hey1 (NM_010423;
clones TRCN0000086479-86480-86481-86482 and TRCN0000311840). MISSION non-target
shRNA control transduction particles (SHC002V) were used as negative control. Puromycin-
resistant preadipocytes with or without Coup-tfII orHey1 gene silencing were differentiated
into mature adipocytes as described below.
Culture and differentiation of 3T3-F442A preadipocytes. 3T3-F442A murine preadipo-
cytes were grown in DMEM (ThermoFisher Scientific, Gent, Belgium) supplemented with 10%
fetal bovine serum (ThermoFisher Scientific) and 5% penicillin/streptomycin (ThermoFisher
Scientific) and were passaged when pre-confluent. To induce differentiation, cells were seeded
at a density of 25 x 103 cells/cm2 and differentiated as described elsewhere [18]. To monitor the
extent of differentiation, RNA was collected at different time points, and cultures were stained
with Oil Red O, as described [18, 19]. Cell extracts of preadipocytes (day 0) and differentiated
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cells (day 12) were prepared in RIPA buffer (Sigma-Aldrich) and the protein concentration
was measured with the bicinchoninic acid method (ThermoFisher Scientific) according to the
manufacturer’s instructions. Samples were stored at -80°C
DAPT treatment. To efficiently block the γ-secretase complex, thereby completely block-
ing Notch responses during differentiation, 3T3-F442A cells were treated with 10 μM of N-[N-
(3,5-Difluorophenacetyl-L-alanyl)]-(S)-phenylglycine t-butyl-ester (DAPT; Calbiochem, San
Diego, CA) dissolved in DMSO.
In vivo and ex vivo models
De novo adipogenesis in vivo. To induce de novo fat pad formation, 10 x 106 3T3-F442A
preadipocytes (with or without gene silencing), grown to near confluency and resuspended in
phosphate buffered saline (PBS), were injected subcutaneously in the back of 6 week old male
athymic Balb/c NUDE mice (Charles River, Les Oncins, France) [20–22]. Mice were kept in
microisolation cages on a 12h day/night cycle and fed with high fat diet (HFD, Harlan Teklad
TD88137, Zeist, The Netherlands; 42% kcal as fat, caloric value 20.1 kJ/g) for 4 weeks. Body
weight was measured weekly. At the end of the experiment, after 6 hours fasting, mice were
anesthetized by intraperitoneal injection of 60 mg/kg Nembutal (Abbott Laboratories, North
Chicago, IL). Intra-abdominal (gonadal, GN), inguinal subcutaneous (SC) and de novo formed
fat pads were removed and weighed; portions were snap-frozen in liquid nitrogen for RNA
extraction and paraffin sections (7 μm) were prepared for histology.
Diet induced obesity. Male C57BL6/N mice, from the age of 5 weeks on, were kept in
microisolation cages on a 12h day/night cycle and fed for 15 weeks with a HFD or a standard
fat diet (SFD, KM-04-k12, Muracon, Carfil, Oud-Turnhout, Belgium; 13% kcal as fat, caloric
value 10.9 kJ/g). At the end of the experiments SC and GN adipose tissues were collected and
treated as described above.
Isolation of adipocytes, stromal vascular fractions and endothelial cells. De novo
formed fat pads from NUDE mice and SC and GN adipose tissues from lean (SFD) and obese
(HFD) WT (C57BL6/N) mice were obtained as described above and used to separate adipo-
cytes from the stromal vascular cell fraction (SVF) by collagenase treatment, as described else-
where [23, 24]. The two cell populations were used for RNA extraction.
To further isolate microvascular endothelial cells (MEC), the SVF was filtered through a
40-μm cell strainer, transferred to Histopaque-1077 solution (Sigma-Aldrich) and centrifuged at
400 g. To obtain pure MEC, a combination of two immunomagnetic selections was performed;
first a negative selection (rat anti-mouse CD45 antibody, Biolegend; San Diego, CA) for enrich-
ment of CD45- cells containing MEC, followed by a positive selection for the purification of
MEC, using specific markers including CD31 (rat anti-mouse CD31, Biolegend), CD102 (rat
anti-mouse CD102 antibody, Biolegend) and isolectin B4 (FITC-labeled isolectin B4, GSI-B4,
Vector Laboratories; Burlingame, CA) [25]. After separation, the freshly isolated MEC were cul-
tured in EGM-2MVmedia (Lonza, Walkersville, MD) supplemented with 10% FBS (Lonza) on
dishes coated with 1.5% gelatin (Sigma-Aldrich). MEC were collected for RNA extraction.
All animal experiments were approved by the local ethical committee of the University of
Leuven (KU Leuven, Leuven, Belgium) (KU Leuven P082-2011) and performed in accordance
with the NIH Guide for the Care and use of Laboratory Animals (1996).
Assays
Gene expression studies. Isolation of total RNA from differentiated cells and SC, GN and
de novo adipose tissue as well as isolated cell fractions was performed using the RNeasy Mini
kit (Qiagen, Basel, Switzerland) according to the manufacturer’s protocol.
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mRNA expression levels were determined by quantitative real time PCR, as described else-
where [26]. The sequences of primers and probes used for Pref1, GPDH, PPAR-γ and aP2 are
described elsewhere [26]. Taqman gene expression assays (ThermoFisher Scientific) were used to
amplify adiponectin (Mm00456425_m1), CD36 (Mm00432403_m), F4/80 (Mm00802529_m1),
Notch1 (Mm004352249_m1), Notch 2 (Mm00803077_m1), Hey1 (Mm00468865_m1), Hey2
(Mm00469280_m1), Hes1 (Mm01342805_m1), CAAT enhancer binding protein alpha (C/EBPα;
Mm00514283_s1), beta (C/EBPβ; Mm00843434_s1), delta (C/EBPδ; Mm00786711_s1) and the
housekeeping gene ß-actin (ßact, Mm01205647_g1).
Analyses were performed by the delta-delta CT method using the 7500 System SDS software
(ThermoFisher Scientific); fold changes were calculated as 2-deltadeltaCT relative to control cells
on day 0 for in vitro experiments, relative to fat pads formed by control cells for de novo adipo-
genesis models, or relative to WT mice on SFD for in vivo studies.
Histological analysis. The size and density of adipocytes or blood vessels in the adipose
tissues were determined by staining with haematoxylin/eosin under standard conditions or
with the Bandeiraea Simplicifolia lectin (Sigma-Aldrich), [22, 27, 28]. Macrophages were
stained with an F4/80 antibody (Serotec, Puchheim, Germany) followed by signal amplification
with the tyramide signal amplification biotin system (Perkin Elmer, Waltham, MA) and visual-
ization through the use of a streptavidin-enzyme conjugate, followed by diaminobenzidine
(DAB). Subsequently, the macrophages were quantified as stained area per total section area.
Collagen content was determined by staining with Sirius red and quantified as percentage
stained area per total section area [29]. Analyses were performed using a Zeiss Axioplan 2
microscope with the AxioVision rel. 4.8 software (Carl Zeiss, Oberkochen, Germany). For each
animal at least 3 pictures from at least 3 sections were made.
COUP-TFII protein determination. Protein levels of COUP-TFII were monitored by
Western bloting, under reducing conditions, using protein extracts (50 μg). Non specific bind-
ing was blocked by incubation of the membranes with 5% non fat milk at room temperature
for 2 hours, followed by overnight incubation with the primary antibody against COUP-TFII
(PP-H7147-00, Perseus Proteomics Inc., Tokyo, Japan) at 4°C. Goat anti-mouse IgG (1/1000;
Dako, Heverlee, Belgium) conjugated with horseradish peroxidase was used as the secondary
antibody and the signal was detected with a chemi-luminescence kit (ThermoFisher Scientific).
ß-actin (13E5, Cell signaling Technology, Danvers, MA) was used as loading control. Blots
were analysed by densitometry, using ImageJ software (http://rsbweb.nih.gov/ij/).
Statistical analysis
Data are reported as means ± SEM. Statistical significance between groups is analyzed by non-
parametric Mann-Whitney U-test or by two-way-ANOVA for time courses of expression. Cor-
relation analysis was performed using the non-parametric Spearman rank correlation test. Val-
ues of p< 0.05 are considered statistically significant.
Results
Role of COUP-TFII in in vitro differentiation of preadipocytes
Using Mission TRC shRNA lentiviral particles directed against Coup-tfII, stable knockdown of
Coup-tfII gene expression was achieved in 3T3-F442A preadipocytes with 5 different plasmids,
amounting to 70% downregulation as compared to the control plasmid SHC002V (2V) (S1A
Fig). The best plasmids #26232 (#1 CouptfII kd) and #54475 (#2 CouptfII kd) were selected for
further experiments. No significant change in Coup-tfII gene expression level was observed
upon transduction with the control plasmid SHC002V as compared to non-transduced
3T3-F442A cells (not shown). Gene silencing was associated with a significant decrease of
COUP-TFII and Adipogenesis
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Coup-tfII (>90% for #2 CouptfII kd) at protein level in cell extracts, as confirmed by Western
blotting (Fig 1A). Quantitative analysis of the ratio COUP-TFII/ ß-actin for both clones con-
firmed this (0.06 ± 0.04 and 0.17 ± 0.06 versus 0.75 ± 0.1, both p< 0.05 for plasmids #2 and
# 1 CouptfII kd versus 2V control, respectively). Coup-tfIImRNA expression upon gene silenc-
ing was stable during the 12-day differentiation period (Fig 1B).
Coup-tfII gene silencing resulted in enhanced differentiation of 3T3-F442A preadipocytes
into mature adipocytes, as visualized by Oil Red O staining and analyzed by light microscopy
(Fig 1C). Quantitative analysis confirmed significantly higher intra-cytoplasmatic lipid content
as compared to control (Fig 1D). Monitoring of adipogenic markers during differentiation of
clone #2 CouptfII kd confirmed lower expression of Pref-1 (Fig 1E) and enhanced expression
levels of PPAR-γ (Fig 1F), CD36 (Fig 1G) and GLUT4 (Fig 1H), compatible with a higher
degree of differentiation upon Coup-tfII gene silencing. The expression level of other pro-adi-
pogenic transcription factors including C/EBPα and C/EBPβ was increased upon knockdown
of Coup-tfII (Fig 1K and 1L), whereas C/EBPδ was suppresed during the early fase of differenti-
ation (Fig 1M).
Monitoring of Notch target genes showed only higher expression of Hey1 upon Coup-tfII
gene silencing (Fig 1I), amounting to 1.7 ± 0.2 fold at day 12. A strong negative correlation was
observed between Hey1 and Coup-tfII expression (Fig 1J). No differences were observed
regarding other Notch signaling genes including Notch1 and Notch2 or the target geneHes1
(S1B–S1D Fig).
Role of Hey1 in in vitro differentiation of preadipocytes
To investigate the hypothesis that Hey1 is involved in the observed stimulation of adipogenesis, a
stable knock-down ofHey1 gene expression was achieved in 3T3-F442A preadipocytes, using the
same approach as described above. Of the five plasmids used for transduction, the plasmid with
strongest gene silencing was selected for further analysis (86482, called clone C2; S2A Fig).
During differentiation of control preadipocytes, Hey1mRNA expression gradually
increased as a function of time, whereas Hey1 gene silencing (Fig 2A) was stable during the
12day-differentiation period. Oil Red O analysis of the intra-cytoplasmatic lipid content of dif-
ferentiated preadipocytes confirmed impaired differentiation uponHey1 silencing (Fig 2B and
2C). Monitoring of adipogenic markers including aP2, PPAR-γ, GPDH, GLUT4 and C/EBPα
during differentiation confirmed lower expression inHey1 knock down cells as compared to
control cells (Fig 2D–2H). No differences in the expression of C/EBPβ, C/EBPδ (Fig 2I and 2J)
Notch1, Notch2 or the target geneHes1 were detected (S2B–S2D Fig).
To investigate the impact of canonical Notch signaling on adipogenesis, 3T3-F442A preadi-
pocytes were differentiated in the presence of the γ-secretase inhibitor DAPT. Inhibitor treat-
ment efficiently blocked Notch signaling, asHes1 and Hey1 were significantly downregulated
(Fig 3A and 3B), as compared to DMSO treated cells. This resulted in enhanced in vitro adipo-
genesis, as confirmed by more intra-cytoplasmatic lipid accumulation upon DAPT treatment
(Fig 3C). However no marked differences were measured in relative expression levels of adipo-
genic markers including aP2, PPAR-γ, GPDH, GLUT4 and Pref-1 (data not shown).
Overall, these findings support our hypothesis that COUP-TFII and Hey1 play a functional
role in preadipocyte differentiation, whereas canonical Notch signaling is dispensable for in
vitro adipogenesis.
Role of COUP-TFII in de novo adipogenesis in vivo
Injection of 3T3-F442A preadipocytes with (clone #2 CouptfII kd) or without (control) Coup-
tfII gene silencing in the back of NUDE mice, resulted in the formation of de novo fat pads
COUP-TFII and Adipogenesis
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after 4 weeks of HFD feeding. Body weight gain was comparable in both groups, resulting in
identical body weights and weights of isolated SC and GN fat depots (Table 1). The weight of
other organs, including spleen, liver, kidney, lung, pancreas and heart was also not affected
(not shown). However, the weight of the de novo formed fat pads from preadipocytes with
Coup-tfII gene silencing was significantly higher as compared to controls (Table 1). Histologi-
cal analysis of sections of de novo adipose tissue revealed no differences in the size of the adipo-
cytes, but a larger adipocyte density in the fat pads formed from the Coup-tfII knockdown cells
(Table 1, Fig 4A and 4B). This is consistent with more adipocytes per area, indicating more adi-
pogenesis. Blood vessel size and density were not significantly different in both groups. Staining
of adipose tissue sections with anti-F4/80 antibody indicated similar macrophage content in
the sections with or without Coup-tfII gene silencing, and quantitative analysis confirmed com-
parable macrophage density. Total collagen levels, measured by Sirius Red staining, in the de
novo formed fat pads were also similar for both groups (Table 1).
However, overall Coup-tfII expression in the de novo fat pads was similar with or without
gene silencing in the preadipocytes (1.02 ± 0.07 vs 1.1 ± 0.08 for 2V vs Coup-tfII kd; p> 0.05,
see below). To further confirm our hypothesis that Coup-tfII gene silencing enhances in vivo
adipogenesis we monitored relative aP2 mRNA expression, showing significantly upregulated
aP2 expression in the fat pads formed upon injection of Coup-tfII knockdown cells as com-
pared to control fat pads (S3A Fig).
Role of Hey1 in de novo adipogenesis in vivo
To further investigate the effect of Hey1 on de novo adipogenesis, 3T3-F442A preadipocytes
with (clone C2) or without (control)Hey1 gene silencing were injected in the back of NUDE
mice, resulting in the formation of de novo fat pads after 4 weeks of HFD feeding. Body weights
and weights of isolated SC and GN fat depots were not different between both groups. As
expected, de novo adipogenesis was impaired uponHey1 gene silencing, shown by a lower fat
pad mass and a smaller size of the adipocytes and lower adipocyte density (Table 2, Fig 4C and
4D). Monitoring of overall Hey1 expression in the de novo fat pads showed a higher expression
in the fat pads formed after injection ofHey1 knockdown cells (1.0 ± 0.06 vs 1.3 ± 0.07 for 2V
vs Hey1 kd; p = 0.02, see below). To further confirm our hypothesis that Hey1 gene silencing
inhibits in vivo adipogenesis we monitored relative aP2 mRNA expression, showing signifi-
cantly decreased aP2 expression in the fat pads formed upon injection of Hey1 knockdown
cells as compared to control fat pads (S3B Fig).
Overall, these data indicate that Hey1 plays an important functional role in in vivo
adipogenesis.
COUP-TFII and Hey1 expression in adipose tissues
To evaluate Coup-tfII and Hey1 expression in adipose tissue and isolated adipocytes during
development of obesity, male C57BL6/N mice, from the age of 5 weeks on, were kept on SFD
Fig 1. Effect of Coup-tfII gene silencing on in vitro differentiation of 3T3-F442A preadipocytes. (A) Western blotting of COUP-TFII protein in extracts of
cells without (control) or with (clone #1 and #2 CouptfII kd) gene silencing; lane M represents the protein marker (50 kDa) and Pos represents a positive
control. (B) Time course of Coup-tfII expression during differentiation without (⚫, black circles) or with (4, open triangles) knockdown (kd). (C-D) Oil Red O
staining (C) and quantification; OD at 490 nm (D) at day 12 of differentiation. (E-H) Time course of expression of Pref-1 (E), PPAR-γ (F), CD36 (G) and
GLUT4 (H) during differentiation without (⚫, black circles) or with (4, open triangles) gene silencing. (I) Time course of Hey1 expression without (⚫, black
circles) or with (4, open triangles) Coup-tfII knockdown (kd). (J) Correlation between expression (delta CT levels) of Coup-tfII andHey1 with or without
Coup-tfII knockdown. (K-M) Time course of expression of C/EBPα (K), C/EBPβ (L) andC/EBPδ (M) during differentiation without (⚫, black circles) or with (4,
open triangles) gene silencing. Data are means ± SEM of 3 independent experiments; * p < 0.05; ** p<0.01; *** p<0.001; **** p<0.0001 versus control.
The scale bar in panel C corresponds to 100 μm
doi:10.1371/journal.pone.0145608.g001
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or HFD for 15 weeks. Coup-tfII expression in GN and SC adipose tissue was lower upon HFD
as compared to SFD feeding (Fig 5A). A strong negative correlation was observed between
Coup-tfII expression and the GN (r = -0.81; p = 0.002) or SC (r = -0.77; p = 0.003) adipose tis-
sue mass. However,Hey1 expression was only slightly increased in GN fat upon HFD feeding
(Fig 5B). In isolated adipocytes from SC or GN fat of obese mice, expression of Coup-tfII was
lower as compared to those from lean mice (Fig 5A), whereas expression of Hey1 was slightly
but not significantly higher (p = 0.07 or p = 0.09 for SC or GN) (Fig 5B). In addition, relative
expression of Coup-tfII was also decreased in the SVF from obese SC or GN adipose tissues,
whereas Hey1 expression in SVF did not differ between obese and lean mice (Fig 5A and 5B).
Purity of isolated adipocytes and SVF was confirmed by on the expression of the adipocyte spe-
cific marker adiponectin and the macrophage marker F4/80 (data not shown).
As adipocytes and endothelial cells may have a common progenitor, we also investigated
the expression of these genes in isolated MEC from SC and GN adipose tissues from lean and
obese mice. Similar as in adipocytes, Coup-tfII expression (Fig 5A) was significantly lower,
whereas Hey1 expression (Fig 5B) was higher in isolated MEC from SC or GN adipose tissues
of obese mice as compared to those of lean controls. Overall, Coup-tfII andHey1 appear to fol-
low a similar expression pattern in adipose tissue, adipocytes and endothelial cells upon induc-
tion of diet-induced obesity.
In addition, we monitored expression of Coup-tfII and Hey1 in isolated adipocytes and SVF
of de novo fat pads formed following injection of 3T3-F442A preadipocytes in the back of
NUDE mice. Purity of the cell fractions was evidenced by higher expression of the adipocyte
specific adipokine, adiponectin (230 fold, p = 0.002), and the lower expression of the macro-
phage maker F4/80 (3 fold, p = 0.002) in the adipocyte fraction as compared to the SVF.
Expression of Coup-tfII (15 fold, p = 0.002) as well asHey1 (8 fold, p = 0.002) was significantly
higher in the SVF than in the adipocyte fraction, indicating that these genes are expressed by
other cells in the de novo fat pads besides adipocytes. This probably explains our observation
that overall Coup-tfII andHey1 expression in de novo fat pads originating from 3T3-F442A
Fig 2. Effect of Hey1 gene silencing on in vitro differentiation of 3T3-F442A preadipocytes. (A) Time course of Hey1 expression during differentiation
without (⚫, black circles) or with (, open circles) knockdown (kd). (B-C) Oil Red O staining and quantification (OD at 490 nm) at day 12 of differentiation.
(D-J) Time course of expression of aP2 (D), PPAR-γ (E),GPDH (F),GLUT4 (G) C/EBPα (H), C/EBPβ (I) andC/EBPδ (J) during differentiation without (⚫,
black circles) or with (, open circles) knockdown (kd). Data are means ± SEM of 3 independent experiments; *** p < 0.001 **** p < 0.0001. The scale bar
in panel C corresponds to 100 μm
doi:10.1371/journal.pone.0145608.g002
Fig 3. Effect of the γ-secretase inhibitor, DAPT, on differentiation of 3T3-F442A preadipocytes. (A-B) Time course ofHey1 (A) andHes1 (B) during
differentiation without (⚫, black circles) or with (⬛, black squares) DAPT treatment. (C) The extent of differentiation as monitored by Oil Red O staining. Data
are means ± SEM of 3 independent experiments; * p < 0.05, ** p < 0.01, **** p < 0.0001.
doi:10.1371/journal.pone.0145608.g003
COUP-TFII and Adipogenesis
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preadipocytes with gene silencing was not significantly downregulated as compared to controls
(see above).
Discussion
COUP-TFII belongs to the steroid/thyroid hormone receptor superfamily and may contribute
to the pathogenesis of obesity. It has not conclusively been established, however, whether its
role is pro- or anti-adipogenic. Indeed, several groups reported an anti-adipogenic role of
COUP-TFII in adipogenesis based on in vitro experiments [4, 5]. This is in contrast with the
only in vivo data available showing that heterozygous COUP-TFII mice have less adipose tissue
as compared to wild-type mice [2]. As far as we know, we are the first group to investigate the
role of COUP-TFII in adipogenesis based on a combination of established mouse models of in
vitro adipocyte differentiation and in vivo adipogenesis. In agreement with the results of Oka-
mura et al. [4] and Xu et al. [5], we found that gene silencing of Coup-tfII in 3T3-F442A preadi-
pocytes, resulted in enhanced differentiation into mature adipocytes. In vivo, de novo fat pad
formation in NUDE mice was significantly stimulated following injection of preadipocytes
with Coup-tfII gene silencing. Interestingly, in our study, Coup-tfII gene silencing was associ-
ated with up-regulation of the Notch signaling target geneHey1. A functional role of Hey1 in
adipogenesis was further confirmed by gene silencing in 3T3-F442A preadipocytes, resulting in
impaired differentiation and in reduced de novo adipogenesis. Interestingly, this established de
novomodel combines the features of in vitro cell lines with the stringency of an in vivo environ-
ment. Furthermore, this model was previously shown to be reprsentative for de novo adipogen-
esis and adipose tissue formation [20–22]. Indeed, Mandrup et al., showed that implanted
preadipocytes harboring a beta-galactosidase transgene gave rise to fat pads in which almost all
adipocytes expressed beta-galactosidase [20].
It is assumed that COUP-TFII is a major regulator of Notch signaling pathways, but, con-
flicting data have been reported on the role of Notch signaling in adipogenesis [9–15]. Thus,
Huang et al. [13] reported that blocking canonical Notch signaling enhances adipogenesis of
adipose derived stem cells (ASC), an earlier stage than 3T3-F442A preadipocytes. However,
Table 1. Body weight and fat depots of NUDEmice injected with 3T3-F442A preadipocytes with or
without COUP-TFII gene silencing and kept on HFD for 4 weeks. Data are means ± SEM of n experi-
ments. SC, subcutaneous; GN, gonadal; COUP-TFII kd (COUP-TFII gene silencing).
COUP-TFII kd (n = 15) Control (n = 13)
Body weight start (g) 20 ± 0.20 20 ± 0.30
Body weight end (g) 23.9 ± 0.50 22.6 ± 0.40
Body weight gain (g) 4.0 ± 0.30 4.0 ± 0.20
SC fat (mg) 225 ± 13 188 ± 17
GN fat (mg) 378 ± 13 309 ± 29
De novo fat
Weight (mg) 34 ± 1.6** 27 ± 1.4
Adipocyte size (μm2) 736 ± 56 681 ± 39
Adipocyte density (x10-6/μm2) 559 ± 50* 458 ± 41
Blood vessel size (μm2) 22 ± 2.0 22 ± 1.0
Blood vessel density (x10-6/μm2) 747 ± 93 649 ± 59
Macrophage content (%) 1.7 ± 0.86 1.8 ± 0.34
Collagen content (%) 35 ± 1.8 31 ± 1.0
* and ** p < 0.05 and p < 0.001 versus control (Mann-Withney U-test)
doi:10.1371/journal.pone.0145608.t001
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Jagged-1-mediated activation of Notch signaling was also found to induce adipogenesis of ASC
[12]. In contrast, Jung et al. showed that silk peptides, that lower body fat, block adipocyte dif-
ferentiation (in C3H10T1/2 and 3T3-L1 cells) to a similar extent as known Notch signaling
inhibitors, including DAPT [11]. DAPT is an inhibitor of canonical Notch signaling, that
Fig 4. H&E Staining of de novo fat pads formed upon injection in NUDEmice of control preadipocytes. (A and C) or of preadipocytes with Coup-tfII
knockdown (B) or Hey1 knockdown (D). The scale bar corresponds to 100 μm.
doi:10.1371/journal.pone.0145608.g004
Table 2. Body weight and fat depots of NUDEmice injected with 3T3-F442A preadipocytes with or
without Hey1 gene silencing and kept on HFD for 4 weeks. Data are means ± SEM of n experiments. SC,
subcutaneous; GN, gonadal; Hey1 kd (Hey1 gene silencing).
Hey1 kd (n = 8) Control (n = 8)
Body weight start (g) 23 ± 0.75* 20 ± 0.60
Body weight end (g) 24 ± 0.61 24 ± 0.47
Body weight gain (g) 2.0 ± 0.30 3.0 ± 0.60
SC fat (mg) 190 ± 21 204 ± 19
GN fat (mg) 350 ± 40 298 ± 18
De novo fat
Weight (mg) 12 ± 0.75*** 21 ± 1.6
Adipocyte size (μm2) 404 ± 46*** 879 ± 43
Adipocyte density (x10-6/μm2) 124 ± 20*** 385 ± 44
* and *** p < 0.05 and p < 0.0001 versus control (Mann-Withney U-test).
doi:10.1371/journal.pone.0145608.t002
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blocks the γ-secretase, which cleaves the Notch receptors to generate the Notch intracellular
domain (NICD) that activates the transcription of several target genes. Our data with DAPT
treatment show that canonical Notch signaling is dispensable for adipogenesis, indicating that
repression of its target genes Hey1,Hes1 and potentially others does not affect adipocyte differ-
entiation, whereas specific gene silencing ofHey1 does inhibit adipogenesis. Since Hey1 and
Hes1 are not the only targets of Notch signaling, DAPT may affect other target genes and
thereby counteract the inhibiting effect of blocking Hey1 on adipogenesis.
Hey1 expression is increased when Coup-tfII is knocked down in the adipocytes, but wether
this effect is due to a direct regulation ofHey1 expression by Coup-tfII needs further investiga-
tion. Aranguren et al. showed that COUP-TFII homodimers have the potential to bind directly
to the promoter regions of the Notch target genes Hey1 and Hey2 in vascular and lymphatic
endothelial cells, causing transcriptional repression [7]. In addition, it was earlier stated in the
literature that white adipocytes are derived from endothelial and haematopoietic lineages [30–
32]. These data strengthen our findings that COUP-TFII plays an anti-adipogenic role via
downregulating the Notch signaling target gene Hey1. To confirm this hypothesis we investi-
gated the expression of Coup-tfII and Hey1 in a model of diet induced obesity. We found that
in WT mice, expression of Coup-tfII in adipose tissue decreased with nutritionally induced
obesity and was negatively correlated with adipose tissue mass. In isolated adipocytes of obese
adipose tissues, as compared to lean controls, expression of Coup-tfII decreased whereas that of
Hey1 increased. It was previously shown that endothelial cells and adipocytes have a common
progenitor [8]. Interestingly, we found that Coup-tfII and Hey1 follow a similar expression pat-
tern in adipose tissue adipocytes and endothelial cells upon induction of diet-induced obesity.
Thus, our data are compatible with the following mechanism: COUP-TFII binds directly to
the promoter of the Notch signaling target gene Hey1 thereby blocking its promoting effect on
adipocyte differentiation and adipogenesis. However, the requirement and role of the
COUP-TFII/Hey1 signaling in adipose tissue development and adipocyte differentiation and
Fig 5. Expression of Coup-tfII andHey1 in adipose tissue and isolated cell fractions. Expression of Coup-tfII (A) or Hey1 (B) in gonadal (GN) and
subcutaneous (SC) adipose tissues, as well as in isolated adipocytes and stromal vascular fractions (SVF) and in microvascular endothelial cells (MEC)
derived from SC and GN adipose tissues obtained from obese mice, is shown relative to samples from lean mice (dotted line). Data are means ± SEM of at
least 4 samples; * p < 0.05, ** p < 0.01, *** p < 0.001.
doi:10.1371/journal.pone.0145608.g005
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its potential as future strategy to treat obesity and its related metabolic diseases need further
investigation.
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